best stocks to invest today

Even amidst slowing growth, Twitter is having to refund advertisers owing to an ad-metric error. Should you sell out of TWTR stock? Or should you buy the dip?

Flickr

Not long after Facebook (NSDQ:FB)reported a spate of miscalculations in key metrics, Twitter (NYSE:TWTR) seems to have caught the ‘bug’. Late on 22nd December, Twitter announced that it had discovered technical errors which “affected some video ad campaigns” Unlike in Facebook’s case though, Twitter’s measurement errors will cost the company directly in Dollar terms.

best stocks to invest today: TSR Inc.(TSRI)

Advisors’ Opinion:

  • [By Lisa Levin]

    TSR Inc (NASDAQ: TSRI) shares shot up 35 percent to $5.15 following Q4 results. TSR reported Q4 earnings of $0.09 per share on revenue of $15.5 million.

best stocks to invest today: ResMed Inc.(RMD)

Advisors’ Opinion:

  • [By STOCKPICKR]

    Medical equipment maker ResMed (RMD) is another name that’s starting to look “toppy” after a bullish start to the year. RMD has more or less kept pace with the S&P 500 in 2014, climbing just over 11% from January to today — but shares started forming a long-term triple-top over the summer, and that setup is getting close to completion this fall.

    It’s worth noting that long-term price setups come with equally long term trading implications when they trigger.

    The triple-top that RMD is showing is a fairly rare pattern, but the trigger is pretty perfunctory: if shares break down below support at $48, then sellers are in control, and it’s time to unload them. Downside isn’t a foregone conclusion in ResMed, but this setup only gets invalidated if shares can close above their prior highs at $54.

best stocks to invest today: Container Store (The)(TCS)

Advisors’ Opinion:

  • [By Monica Gerson]

    Container Store Group Inc (NYSE: TCS) is expected to post its quarterly earnings at $0.21 per share on revenue of $230.53 million.

    J & J Snack Foods Corp (NASDAQ: JJSF) is estimated to post its quarterly earnings at $0.78 per share on revenue of $231.58 million.

  • [By Lisa Levin]

    Container Store Group Inc (NYSE: TCS) shares shot up 27 percent to $5.29 after the company posted upbeat results for its fourth quarter and issued a strong forecast for FY 2017.

best stocks to invest today: US Foods Holding Corp. (USFD)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Guggenheim’sJohn Heinbockel and team argue that a “purging of space is necessary” in retail, and recommend hiding in “industry leaders who canprofitably gain share and are not especially expensive,” like Michaels (MIK), Tractor Supply (TSCO), Restoration Hardware (RH), Kroger (KR),and US Foods Holding (USFD). They explain:

  • [By Jayson Derrick]

    But Amazon’s ultimate end-goal would likely be turning stores into “centralized distribution centers for groceries” but “we err on the futuristic side given Bezos thinks big.”

    Company Commentary
    Kroger Co (NYSE: KR) may be best positioned to counter Amazon’s threat given its own data analytics capabilities. SYSCO Corporation (NYSE: SYY) and US Foods Holding Corp (NYSE: USFD) are likely safe as Amazon won’t move into the foodservice distribution space which is very different from serving individual customers.

    Related Links:

best stocks to invest today: Home Depot, Inc. (The)(HD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Who are the likely candidates for the next round of upgrades? Cramer said he’s betting that 3M (MMM) will be in the mix, along with Walmart (WMT) and especially Home Depot (HD) , which should have a strong spring planting season with good comparisons to last year. Investors might also see upgrades on Honeywell (HON) and Nike (NKE) , Cramer suggested.

  • [By Craig Jones]

    Mike Khouw spoke on CNBC's Options Action about unusually high call options activity in Home Depot Inc (NYSE: HD). The company is going to report earnings on Tuesday and it moves on average 2.8 percent on the event. The options market is currently implying a move of 2.4 percent.

  • [By Paul Ausick]

    The DJIA stock posting the largest daily percentage loss ahead of the close Friday was The Home Depot Inc. (NYSE: HD) which traded down 2.73% at $151.24. The stock’s 52-week range is $119.20 to $160.86. Volume was about 75% above the daily average of around 4.1 million shares. The company had no specific news, but we noted a lawsuit against Home Depot that is exceedingly strange. 247wallst.com/retail/2017/06/23/are-you-being-cheated-when-you-buy-lumber-at-home-depot/

  • [By The Ticker Tape]

    Homebuilders like Lennar, PulteGroup, Inc. (NYSE: PHM), and D.R. Horton, Inc. (NYSE: DHI) could benefit from a strengthening housing recovery. If you’re bullish on housing, you might want to take a step back and think about other companies in that space. Home improvement stores like Home Depot Inc (NYSE: HD) and Lowe's Companies, Inc. (NYSE: LOW) could get a boost as well as companies that supply products for new homes like Whirlpool Corporation (NYSE: WHR) and USG Corporation(NYSE: USG).

best stocks to invest today: The NeutriSci International (NU)

Advisors’ Opinion:

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Matthew Briar]

    Indeed, it’s also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

  • [By Bryan Murphy]

    In the grand scheme of things it shouldn’t be surprising, though odds are good at least a few people are surprised at how quickly it happened. That is, health supplement and healthy-foods brand name NeutriSci International Inc (CVE:NU) and the developer of a cannabis-infusion technology — a means of packing more CBD into hemp oil — called Lexaria Bioscience Corp (OTCMKTS:LXRP) have finalized new supplement that is done testing and will soon be available for consumers. The tablet (a ‘melt’, technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.

    The benefits of cannabidiol, found in hemp and marijuana, are relatively well understood by the market at this point. Cannabidiol can do a human body a lot of good, like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more. Pterostilbene is the lesser-known of the two components of the new tablet, but no less impressive and no less beneficial. Pterostilbene is known to combat high cholesterol, high blood pressure, and oxidative stress. Combining the two is a real one-two punch for the health-conscious.

    That’s what made November’s news so exciting… NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional. Indeed, to fully appreciate the upside for LXRP, one has to embrace Lexaria’s science and why it matters.

    The bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short,

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

Leave a Reply

Your email address will not be published. Required fields are marked *